Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
- DOI
- 10.1016/s0140-6736(21)00432-3
- Published
- 2021 Mar 6
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-21-00432-3,
title = {Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.},
author = {Voysey M and Costa Clemens SA and Madhi SA and Weckx LY and Folegatti PM and Aley PK and Angus B and Baillie VL and Barnabas SL and Bhorat QE and Bibi S and Briner C and Cicconi P and Clutterbuck EA and Collins AM and Cutland CL and Darton TC and Dheda K and Dold C and Duncan CJA and Emary KRW and Ewer KJ and Flaxman A and Fairlie L and Faust SN and Feng S and Ferreira DM and Finn A and Galiza E and Goodman AL and Green CM and Green CA and Greenland M and Hill C and Hill HC and Hirsch I and Izu A and Jenkin D and Joe CCD and Kerridge S and Koen A and Kwatra G and Lazarus R and Libri V and Lillie PJ and Marchevsky NG and Marshall RP and Mendes AVA and Milan EP and Minassian AM and McGregor A and Mujadidi YF and Nana A and Padayachee SD and Phillips DJ and Pittella A and Plested E and Pollock KM and Ramasamy MN and Ritchie AJ and Robinson H and Schwarzbold AV and Smith A and Song R and Snape MD and Sprinz E and Sutherland RK and Thomson EC and Török ME and Toshner M and Turner DPJ and Vekemans J and Villafana TL and White T and Williams CJ and Douglas AD and Hill AVS and Lambe T and Gilbert SC and Pollard AJ and Oxford COVID Vaccine Trial Group},
year = {2021},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(21)00432-3},
url = {https://doi.org/10.1016/s0140-6736(21)00432-3}
}RIS
TY - JOUR TI - Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. AU - Voysey M AU - Costa Clemens SA AU - Madhi SA AU - Weckx LY AU - Folegatti PM AU - Aley PK AU - Angus B AU - Baillie VL AU - Barnabas SL AU - Bhorat QE AU - Bibi S AU - Briner C AU - Cicconi P AU - Clutterbuck EA AU - Collins AM AU - Cutland CL AU - Darton TC AU - Dheda K AU - Dold C AU - Duncan CJA AU - Emary KRW AU - Ewer KJ AU - Flaxman A AU - Fairlie L AU - Faust SN AU - Feng S AU - Ferreira DM AU - Finn A AU - Galiza E AU - Goodman AL AU - Green CM AU - Green CA AU - Greenland M AU - Hill C AU - Hill HC AU - Hirsch I AU - Izu A AU - Jenkin D AU - Joe CCD AU - Kerridge S AU - Koen A AU - Kwatra G AU - Lazarus R AU - Libri V AU - Lillie PJ AU - Marchevsky NG AU - Marshall RP AU - Mendes AVA AU - Milan EP AU - Minassian AM AU - McGregor A AU - Mujadidi YF AU - Nana A AU - Padayachee SD AU - Phillips DJ AU - Pittella A AU - Plested E AU - Pollock KM AU - Ramasamy MN AU - Ritchie AJ AU - Robinson H AU - Schwarzbold AV AU - Smith A AU - Song R AU - Snape MD AU - Sprinz E AU - Sutherland RK AU - Thomson EC AU - Török ME AU - Toshner M AU - Turner DPJ AU - Vekemans J AU - Villafana TL AU - White T AU - Williams CJ AU - Douglas AD AU - Hill AVS AU - Lambe T AU - Gilbert SC AU - Pollard AJ AU - Oxford COVID Vaccine Trial Group PY - 2021 JO - Lancet (London, England) DO - 10.1016/s0140-6736(21)00432-3 UR - https://doi.org/10.1016/s0140-6736(21)00432-3 ER -
APA
M, V., SA, C. C., SA, M., LY, W., PM, F., PK, A., B, A., VL, B., SL, B., QE, B., S, B., C, B., P, C., EA, C., AM, C., CL, C., TC, D., K, D., C, D., CJA, D., KRW, E., KJ, E., A, F., L, F., SN, F., S, F., DM, F., A, F., E, G., AL, G., CM, G., CA, G., M, G., C, H., HC, H., I, H., A, I., D, J., CCD, J., S, K., A, K., G, K., R, L., V, L., PJ, L., NG, M., RP, M., AVA, M., EP, M., AM, M., A, M., YF, M., A, N., SD, P., DJ, P., A, P., E, P., KM, P., MN, R., AJ, R., H, R., AV, S., A, S., R, S., MD, S., E, S., RK, S., EC, T., ME, T., M, T., DPJ, T., J, V., TL, V., T, W., CJ, W., AD, D., AVS, H., T, L., SC, G., AJ, P., & Group, O. C. V. T. (2021). Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(21)00432-3
Source records
- pubmed · retrieved 2026-09-25T16:52:56.337Z